Stock Market

by Charles Hugh-Smith The heretical truth is that many of the “consumption rituals” that signified “prosperity” for decades are either meaningless, unaffordable or require way more effort than the meager payoff is worth. Of all the economic heresies imaginable, perhaps the most heretical is to recognize what we label “prosperity” as increasingly meaningless rituals more akin
0 Comments
Johnson & Johnson said that Phase1/2 trial data showed that a single dose of its COVID-19 vaccine candidate, JNJ-78436735, induced a “strong” neutralizing antibody response in nearly all participants aged 18 years and older. Interim analysis from the ongoing Phase 1/2a clinical trial demonstrated that J&J’s (JNJ) vaccine candidate was generally well-tolerated. Immune responses were
0 Comments
by Frank Shostak via Mises According to the modern portfolio theory (MPT), financial asset prices always fully reflect all available and relevant information, and any adjustment to new information is virtually instantaneous. In this way of thinking, asset prices respond only to the unexpected part of any information, since the expected part is already embedded in prices. For
0 Comments
Among the devastating impacts of COVID-19 on businesses, advertising budgets have been hit hard. Even Wall Street heavyweight Facebook’s (FB) advertising business has been battered by the pandemic, with an advertiser boycott also weighing on the segment. In the second quarter of 2020, the company’s top 100 advertisers accounted for 16% of its revenue, which
0 Comments
by Kimble Charting Inflation has long been a word that the Federal Reserve uses but the general markets have forgotten about. Why? Well because it’s been virtually non-existent for years. Key indicators like commodities (i.e. copper) have been in a down-trends and the Materials Sector (XLB) has lagged… until this year. In today’s chart 3-pack, we take a
0 Comments
Does AstraZeneca (AZN) still have a fighting chance in the COVID-19 vaccine race? Earlier this month, the healthcare giant paused the Phase 3 study of AZD1222, its experimental COVID-19 vaccine developed as part of a collaboration with the University of Oxford, after one of the participants developed an unexplained illness, a potential adverse effect. This
0 Comments
Take a look at some of the biggest movers in the premarket: Costco (COST) – Costco reported quarterly earnings of $3.04 per share, 20 cents a share above estimates. The warehouse retailer’s revenue also beat Wall Street forecasts. Comparable-store sales rose 11.4% compared to the 7.8% consensus estimate of analysts polled by Refinitiv. Costco also
0 Comments
It’s been a couple of week now since SVB Leerink analyst Mani Foroohar cited worries about increased competition in the CVOID-19 vaccine race (200 vaccines in process, dozens in clinical trials), and mRNA-1273 lost “lead in clinical development” in deciding to downgrade Moderna (MRNA) stock to “underperform.” A couple of weeks later… he’s still not
0 Comments
by CRESCAT CAPITAL Dear Investors: The Reckoning Is Upon Us Decades of fiscal profligacy are culminating in an explosion of government debt that is poised to bring simmering monetary debasement to a boiling point. Central bank interventions have aided and abetted reckless government spending that has obfuscated poor underlying organic growth fundamentals. Instead of laying the
0 Comments
Avient (AVNT) stock rose 3.4% in after-hours trading on Thursday as the company reported preliminary 3Q numbers and provided an update related to the cost synergies associated with the Clariant Masterbatch acquisition. Avient (formerly PolyOne), a provider of specialized and sustainable material solutions, expects to deliver adjusted EPS of $0.43 in 3Q due to a
0 Comments
Take a look at some of the biggest movers in the premarket: Accenture (ACN) – The consulting firm reported quarterly profit of $1.70 per share, falling 3 cents a share short of Wall Street forecasts. Revenue also came in slightly shy of estimates and the company gave a weaker-than-expected current-quarter revenue forecast, as clients spend less
0 Comments
by CanMurky49 C19 wouldn’t exist if people stopped testing and turned off their tell a vision. Current mortality rate for those whom have tested positive is less than 0.1%, and even that is a colossal overstatement to say the least, if you take into consideration the fact they’ve been pushing the entire world to get tested
0 Comments
by confoundedinterest17 It is difficult to keep an economy down with Covid-related shutdowns. According to the Mortgage Bankers Association applications index, unadjusted purchase applications rose 13.41% for the week ending 09/18. Unadjusted refinancing applications rose 20.92%. Mortgage purchase applications usually peak in late April or early May, but due to Covid, they peaked this year in late
0 Comments
A Tesla Inc. vehicle charges at a charging station in San Mateo, California, U.S., on Tuesday, Sept. 22, 2020. David Paul Morris | Bloomberg | Getty Images Check out the companies making headlines after the bell:  Jefferies Financial Group — Shares of the financial services firm jumped more than 14% following the company’s third quarter
0 Comments
Shoppers, some wearing PPE (personal protective equipment), of a face mask or covering as a precautionary measure against COVID-19, queue to enter a recently re-opened Nike store at Gunwharf Keys shopping centre in Portsmouth, southern England on June 16, 2020. Adrian Dennis | AFP | Getty Images Check out the companies making headlines in midday
0 Comments
Western Digital Corp. has aligned its $16.7 billion worth of storage portfolio and in turn, formed two separate business units for its Flash and Hard Disk Drive (HDD) technology assets. The hard-disk drive manufacturer Western Digital (WDC) said that the strategy “leverages company’s go-to-market synergies to address broad customer storage needs from edge devices to
0 Comments